Cytomorphological Disparities in Invasive Breast Cancer Cells following Neoadjuvant Endocrine Therapy and Chemotherapy
Pathobiology · 2024 · 91 (4) · 288-298
DOI: 10.1159/000538227 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathobiology, online erschienen am 12.03.2024. Verfasst von Hideko Hoshina und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery and Oncology, Nippon Medical School, Tokyo, Japan, s8083@nms.ac.jp. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoadjuvant Therapy, Kinesins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Introduction
Neoadjuvant endocrine therapy (NAE) offers a breast-conserving surgery rate and clinical response rate similar to those of neoadjuvant chemotherapy (NAC), while presenting fewer adverse events and lower pathological complete response rates. The assessment of pathological response determines degenerative changes and predicts the prognosis of breast cancer treated with NAC. This study clarified the degenerative changes occurring in breast cancer following NAE.
Methods
Our study encompassed two groups: NAE, consisting of 15 patients, and NAC, comprising 18 patients. Tissue samples were obtained from core needle biopsies and surgeries. Nuclear and cell areas were calculated using Autocell analysis. Furthermore, we assessed markers associated with microtubule depolymerization (KIF2A) and initiators of apoptosis (caspase-9).
Results
In the NAC group, we observed significant increases in both cytoplasmic and cell areas. These changes in cytoplasm and cells were notably more pronounced in the NAC group compared to the NAE group. After treatment, KIF2A exhibited a decrease, with the magnitude of change being greater in the NET group than in the NAC group. However, no discernible differences were found in caspase-9 expression between the two groups.
Conclusion
Our findings indicate that NAE induces condensation in cancer cells via cell cycle arrest or apoptosis. Conversely, NAC leads to cell enlargement due to the absence of microtubule depolymerization. These discrepancies underscore the importance of accounting for these distinctions when establishing criteria for evaluating pathological responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Surgery and Oncology, Nippon Medical School, Tokyo, Japan, s8083@nms.ac.jp.
- Department of Diagnostic Pathology, Nippon Medical School Hospital, Tokyo, Japan.
- Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo, Japan.
- Department of Breast Surgery and Oncology, Nippon Medical School, Tokyo, Japan.
Zitieren
APA
Hoshina, H., Sakatani, T., Kawamoto, Y., Ohashi, R., & Takei, H. (2024). Cytomorphological Disparities in Invasive Breast Cancer Cells following Neoadjuvant Endocrine Therapy and Chemotherapy. Pathobiology, 91(4), 288-298. https://doi.org/10.1159/000538227
Vancouver
Hoshina H, Sakatani T, Kawamoto Y, Ohashi R, Takei H. Cytomorphological Disparities in Invasive Breast Cancer Cells following Neoadjuvant Endocrine Therapy and Chemotherapy. Pathobiology. 2024;91(4):288-298. doi:10.1159/000538227
BibTeX
@article{Hoshina2024,
author = {Hoshina, Hideko and Sakatani, Takashi and Kawamoto, Yoko and Ohashi, Ryuji and Takei, Hiroyuki},
title = {Cytomorphological Disparities in Invasive Breast Cancer Cells following Neoadjuvant Endocrine Therapy and Chemotherapy},
journal = {Pathobiology},
year = {2024},
volume = {91},
number = {4},
pages = {288--298},
doi = {10.1159/000538227}
}
EUVIMED